Lululemon Athletica Inc vs Sana Biotechnology Inc — how do they compare? Lululemon Athletica Inc trades at $119.96 (market cap $14.26B), while Sana Biotechnology Inc trades at $3.68 (market cap $1.13B). The key difference: Lululemon Athletica Inc is far larger — about 12.6× Sana Biotechnology Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Lululemon Athletica Inc nearer its low. Which is the better fit depends on your goals.
| LULU | SANA | |
|---|---|---|
Market Cap | $14.26B | $1.13B |
Sector | Consumer Cyclical | Health |
52-Week High | $215.88 | $5.92 |
52-Week Low | $105.43 | $2.68 |
Enterprise Value | $14.89B | $1.05B |
Trailing returns across standard periods
Latest headlines on both assets
Lululemon Athletica Inc. designs, distributes, and markets athletic apparel, footwear, and accessories for women, men, and girls. Lululemon offers pants, shorts, tops, and jackets for both leisure and athletic activities such as yoga and running. The company also sells fitness accessories, such as bags, yoga mats, and equipment. Lululemon sells its products through more than 600 company-owned stores in 18 countries, e-commerce, outlets, and wholesale accounts. The company was founded in 1998 and is based in Vancouver, Canada.
Read more on LULU →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →